MBVax Bioscience collaborates with clinical researchers interested in participating in investigator-sponsored clinical trials in cancer. Ideally, clinical investigators will have a research interest in immunology and be associated with institutions with clinical trial experience and an existing stream of appropriate clinical trial candidates. MBVax will provide a clinical trial documentation package including an Investigator’s Brochure, administration protocols and clinical trial templates, and will assist in filing research grant applications.

A clinical investigator in Europe has filed an application for a Coley Fluid clinical trial in sarcoma, melanoma and bladder cancer. This application is under regulatory review.

A group of clinicians in the United States are organizing a clinical trial of Coley Fluid in advanced breast cancer.

Clinical researchers interested in participating or organizing a clinical trial in cancer should contact donmacadam@mbvax.com .